Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: NZ$19.72 Billion

As of October 2024 Neurocrine Biosciences has a market cap of NZ$19.72 Billion. This makes Neurocrine Biosciences the world's 1485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Neurocrine Biosciences was reported to be:

NZ$19.72 Billion

by Yahoo Finance

NZ$19.72 Billion

by CompaniesMarketCap

NZ$19.72 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Repligen RGEN	NZ$13.12 B	-33.45%	🇺🇸 USA
Royalty Pharma RPRX	NZ$27.44 B	39.17%	🇬🇧 UK
Palatin Technologies PTN	NZ$32.23 M	-99.84%	🇺🇸 USA
Eli Lilly LLY	NZ$1.361 T	6,803.74%	🇺🇸 USA
AbbVie ABBV	NZ$549.21 B	2,684.56%	🇺🇸 USA
Pfizer PFE	NZ$273.49 B	1,286.64%	🇺🇸 USA
ANI Pharmaceuticals ANIP	NZ$2.08 B	-89.43%	🇺🇸 USA
Athersys ATHX	NZ$1.37 M	-99.99%	🇺🇸 USA